ION BEAM APPLICATIONS, SA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.86 EUR | -0.77% |
|
-3.02% | +11.44% |
| Mar. 21 | Ion Beam Applications SA to Recommend Dividend for 2023 | CI |
| Mar. 21 | Transcript : Ion Beam Applications SA, 2023 Earnings Call, Mar 21, 2024 |
Presenter SpeechOlivier Lechien (Executives)Hello, and welcome to IBA's Full Year 2023 Results...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Ion Beam Applications, SA (IBA) specializes in the design, manufacture, and marketing of cancer treatment and diagnosis equipment. Net sales break down by family of products as follows:
- diagnosis and therapeutic treatment equipment and systems (84.8%): proton therapy equipment (62.5% of net sales; No. 1 worldwide), and particle accelerators (36.5%) used in the production of radioisotopes (cyclotrons) and in the development of sterilization and ionization solutions (Rhodotron® and Dynamitron®);
- equipment and solutions of dosimetry (15.2%; No. 1 worldwide): measurement and analysis tools of the radiation doses in medical imaging and radiation therapy.
Net sales are distributed geographically as follows: the United States (31.7%) and other (68.3%).
Calendar
2024-05-23
- Q1 2024 Sales and Revenue Release
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
12.86
EUR
Average target price
16.17
EUR
Spread / Average Target
+25.71%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +11.44% | 400M | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +0.65% | 63.06B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B |
- Stock Market
- Equities
- IBAB Stock
- News Ion Beam Applications, SA
- Transcript : Ion Beam Applications SA, 2023 Earnings Call, Mar 21, 2024
